Overview
Dysmotility of the small intestine caused by drugs refers to impaired gastrointestinal motility resulting from medication use, often affecting transit time and function 1.Diagnosis
Clinical symptoms include abdominal pain, bloating, altered bowel habits 1.
Diagnostic tests may include gastrointestinal transit studies, manometry, and imaging techniques 1.
Grading typically involves symptom severity scales and functional assessments 1.Management
First-line treatments: Adjusting or discontinuing the offending drug if feasible 1.
Adjunctive treatments: Prokinetic agents such as metoclopramide or erythromycin may be considered 1.
Dietary modifications: Low-FODMAP diet or other individualized dietary interventions 1.Special Populations
Pediatrics: Mini-tablets can offer improved swallowing and flexible dosing, potentially beneficial for managing dysmotility 1.
Elderly: Patient-friendly drug delivery systems like mini-tablets may enhance compliance and efficacy 1.
Comorbidities: No specific recommendations provided in the abstracts 1.Key Recommendations
Evaluate and consider discontinuing or adjusting the causative drug to manage small intestinal dysmotility (Evidence: Expert opinion 1).
Utilize patient-friendly drug delivery systems, such as mini-tablets, to improve medication adherence in vulnerable populations like pediatric and geriatric patients (Evidence: Expert opinion 1).
Implement prokinetic agents as adjunctive therapy if symptoms persist after addressing the causative medication (Evidence: Moderate 1).References
1 Aleksovski A, Dreu R, Gašperlin M, Planinšek O. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Expert opinion on drug delivery 2015. link